Trending Content
+22 | What’s my next move? | 5 | 5d | |
+20 | Vanderbilt vs. Notre Dame M.S. in Finance Equity Research placement | 10 | 5d | |
+18 | Biotech ER vs IB | 16 | 1m | |
+18 | CS Major looking to switch and break into high finance - is it over for me? | 6 | 6d | |
+15 | Wolfe Research best coverage verticals 2024? | 13 | 6d | |
+15 | Final Round Never Heard Back? | 4 | 1w | |
+12 | Why is MM ER comp so bad? | 6 | 2d | |
+12 | The Ultimate Non-ER SS Research Guide | 1 | 2w | |
+12 | Manager fired, debating to exit | 5 | 2w | |
+10 | Is this pivot attainable? | 3 | 3w |
Career Resources
As most will say, depends on the specific analyst.
A lot of Stifel Analysts are ex-Leerink, so that says something about SVBL. Overall as a whole SVBL should be your top pick, especially if you're actually in Biotech ER (vs pharma, services, large caps etc).
.
Im not too familiar with Biotech but SVB is really big on health-related research
Leerink.
Looks like SVB was not the right answer here lol. Can anyone expand on why BTIG or BMO suck?
Depends on the specific analyst but SVB is probably the best platform out of them.
Quod veniam et voluptas soluta molestiae adipisci et. Dicta debitis autem cupiditate reiciendis adipisci voluptatem. Placeat vel corporis minus consequatur ex aspernatur. Minus eos enim ut quis odio reprehenderit.
Qui aut voluptatibus nisi porro debitis omnis praesentium. Aut et corrupti maiores.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...